fluorodopa f 18 has been researched along with Cannabis Abuse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloomfield, MA; Curran, HV; Egerton, A; Howes, OD; Kapur, S; Morgan, CJ | 1 |
| Bloomfield, MA; Curran, HV; Freeman, TP; Howes, OD; Morgan, CJ; Mouchlianitis, E; Roiser, JP | 1 |
2 other study(ies) available for fluorodopa f 18 and Cannabis Abuse
| Article | Year |
|---|---|
Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms.
Topics: Cannabis; Case-Control Studies; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopaminergic Neurons; Female; Functional Neuroimaging; Humans; Male; Marijuana Abuse; Positron-Emission Tomography; Psychoses, Substance-Induced; Young Adult | 2014 |
Salience attribution and its relationship to cannabis-induced psychotic symptoms.
Topics: Adult; Brain; Cannabis; Case-Control Studies; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Marijuana Abuse; Neostriatum; Positron-Emission Tomography; Psychoses, Substance-Induced; Radiopharmaceuticals; Reward; Young Adult | 2016 |